BG Medicine Inc (BGMD)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CEO:
Paul R. Sohmer
Employees:
5
880 WINTER STREET, SUITE 210, WALTHAM, MA 02451
781-890-1199

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

BG Medicine, Inc. engages in the research and development, clinical research, manufacture and sale of diagnostic products for heart failure and related disorders. It distributes its products such as BGM Galectin-3 to clinical laboratories, hospitals and health care provider. The company was founded in February 2000 and is headquartered in Waltham, MA.

Data derived from most recent annual or quarterly report
Market Cap 284.359 Thousand Shares Outstanding11.374 Million Avg 30-day Volume 16.841 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.18
Price to Revenue2.7467 Debt to Equity0.0 EBITDA-4.543 Million
Price to Book Value0.0 Operating Margin-295.6577 Enterprise Value5.276 Million
Current Ratio1.653 EPS Growth0.273 Quick Ratio1.446
1 Yr BETA 1.6139 52-week High/Low 0.0 / Profit Margin-338.6335
Operating Cash Flow Growth55.0998 Altman Z-Score-113.4464 Free Cash Flow to Firm -2.972 Million
View SEC Filings from BGMD instead.

View recent insider trading info

BG Medicine Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BGMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BGMD

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 3: filed on 2016-06-27 by BG MEDICINE, INC.
  • 4: filed on 2016-05-04 by BG MEDICINE, INC.
  • 4: filed on 2016-04-04 by BG MEDICINE, INC.
  • 4: filed on 2016-04-04 by BG MEDICINE, INC.
  • 4: filed on 2016-04-04 by BG MEDICINE, INC.
  • 4/A: filed on 2016-04-04 by BG MEDICINE, INC.
  • 4/A: filed on 2016-04-04 by BG MEDICINE, INC.
  • 4: filed on 2016-02-05 by BG MEDICINE, INC.
  • 3: filed on 2016-02-05 by BG MEDICINE, INC.
  • 4: filed on 2015-12-11 by BG MEDICINE, INC.

    • Events (8k)

  • 8-K: filed on 2016-03-31:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
  • 8-K: filed on 2016-02-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SEAWELL HAYGOOD PATERSON SR

    • PRIVATE INVESTOR
    		 1,298,965 2016-05-05 0

    HALL STEPHEN P EVP & CHIEF FINANCIAL OFFICER

    • Officer
    		 31,034 2016-03-31 0

    SOHMER PAUL R PRESIDENT & CEO

    • Officer
    • Director
    		 53,161 2016-03-31 0

    ADOURIAN ARAM S. SVP & CHIEF SCIENTIFIC OFFICER

    • Officer
    		 35,770 2016-03-31 0

    LUBER JEFFREY R

    • Director
    		 0 2016-02-04 0

    AFEYAN NOUBAR

    • Director
    • 10% Owner
    		 1,286,274 2015-12-09 0

    WILCOX HARRY W

    • Director
    		 0 2015-11-18 0

    OCONNOR JAMES F O

    • Director
    		 0 2015-11-18 0

    PAPADOPOULOS STELIOS

    • Director
    		 0 2015-11-18 0

    AFEYAN NOUBAR

    FLAGSHIP VENTURES MANAGEMENT, INC.

    NEWCOGEN GROUP, INC.

    AGTC ADVISORS FUND LP

    AGTC PARTNERS, L.P.

    • Director
    • 10% Owner
    		 1,332,712 2015-07-27 0

    AFEYAN NOUBAR

    FLAGSHIP VENTURES MANAGEMENT, INC.

    NEWCOGEN GROUP, INC.

    APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP

    AGTC PARTNERS, L.P.

    • Director
    • 10% Owner
    		 1,328,234 2015-07-27 0

    AFEYAN NOUBAR

    KANIA EDWIN M JR

    FLAGSHIP VENTURES MANAGEMENT, INC.

    NEWCOGEN GROUP, INC.

    AGTC PARTNERS, L.P.

    AGTC ADVISORS FUND LP

    APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP

    FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND 2007, L.P.

    • Director
    • 10% Owner
    		 1,474,443 2015-07-14 0

    FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND 2007, L.P.

    • 10% Owner
    		 441,071 2015-07-14 0

    KANIA EDWIN M JR

    • 10% Owner
    		 5,805,282 2014-12-09 0

    AFEYAN NOUBAR

    NEWCOGEN EQUITY INVESTORS LLC

    KANIA EDWIN M JR

    FLAGSHIP VENTURES MANAGEMENT, INC.

    NEWCOGEN GROUP, INC.

    • Director
    • 10% Owner
    		 7,265,546 2014-12-03 0

    AFEYAN NOUBAR

    NEWCOGEN GROUP LLC

    KANIA EDWIN M JR

    FLAGSHIP VENTURES MANAGEMENT, INC.

    NEWCOGEN GROUP, INC.

    • Director
    • 10% Owner
    		 5,016,493 2014-12-03 0

    AFEYAN NOUBAR

    ST NEWCOGEN LLC

    KANIA EDWIN M JR

    FLAGSHIP VENTURES MANAGEMENT, INC.

    NEWCOGEN GROUP, INC.

    • Director
    • 10% Owner
    		 8,009,400 2014-12-03 0

    AFEYAN NOUBAR

    NEWCOGEN LONG REIGN HOLDING LLC

    KANIA EDWIN M JR

    FLAGSHIP VENTURES MANAGEMENT, INC.

    NEWCOGEN GROUP, INC.

    • Director
    • 10% Owner
    		 7,917,106 2014-12-03 0

    BAINS HARRISON M JR

    • Director
    		 0 2014-06-03 0

    POSNER BRIAN S

    • Director
    		 0 2014-06-03 0

    HARRIS TIMOTHY J.R.

    • Director
    		 0 2014-06-03 0

    BANCEL STEPHANE

    • Director
    		 0 2014-06-03 0

    RADER ANASTASIA SVP, EXECUTIVE OPERATIONS & HR

    • Officer
    		 0 2014-02-04 0

    AFEYAN NOUBAR

    KANIA EDWIN M JR

    FLAGSHIP VENTURES MANAGEMENT, INC.

    NEWCOGEN GROUP, INC.

    NEWCOGEN GROUP LLC

    NEWCOGEN EQUITY INVESTORS LLC

    AGTC PARTNERS, L.P.

    AGTC ADVISORS FUND LP

    APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP

    • Director
    • 10% Owner
    		 8,186,182 2013-01-30 0

    ABDALIAN CHARLES H JR EVP & CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2012-12-10 0

    AFEYAN NOUBAR

    NEWCOGEN ELAN LLC

    KANIA EDWIN M JR

    FLAGSHIP VENTURES MANAGEMENT, INC.

    NEWCOGEN GROUP, INC.

    • Director
    • 10% Owner
    		 6,186,182 2012-08-20 0

    DENSEL WILLIAM GENERAL MANAGER, CARDIOSCORE

    • Officer
    		 0 2012-08-08 0

    MUNTENDAM PIETER EVP, CHIEF MEDICAL OFFICER

    • Officer
    		 78,483 2012-06-07 0

    BOUVIER ERIC PRESIDENT, CEO

    • Officer
    • Director
    		 10,000 2012-05-23 0

    AFEYAN NOUBAR

    NEWCOGEN PE LLC

    KANIA EDWIN M JR

    FLAGSHIP VENTURES MANAGEMENT, INC.

    NEWCOGEN GROUP, INC.

    • Director
    • 10% Owner
    		 6,462,782 2012-05-21 0

    VAN DER MEER PIETER

    GILDE EUROPE FOOD & AGRIBUSINESS FUND B.V.

    GILDE AGRIBUSINESS MANAGEMENT B.V.

    GILDE HEALTHCARE HOLDING B.V.

    DE GRAAF EDWIN

    PERRET MARC OLIVIER

    GILDE EUROPE FOOD & AGRIBUSINESS PARTNERS II C.V.

    • 10% Owner
    		 No longer subject to file 2012-04-17 0

    GORDON NEAL SVP, BIOMARKER DISCOVERY

    • Officer
    		 0 2012-02-22 0

    ROGERS MICHAEL W EVP, CFO AND TREASURER

    • Officer
    		 0 2012-02-22 0

    MILLER STEPHEN R. CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2012-02-22 0

    SHEPHERD WAYNE K. VP, SALES AND MARKETING

    • Officer
    		 0 2011-03-02 0

    AFEYAN NOUBAR

    KANIA EDWIN M JR

    FLAGSHIP VENTURES MANAGEMENT, INC.

    NEWCOGEN GROUP, INC.

    NEWCOGEN GROUP LLC

    NEWCOGEN EQUITY INVESTORS LLC

    NEWCOGEN ELAN LLC

    NEWCOGEN LONG REIGN HOLDING LLC

    NEWCOGEN PE LLC

    ST NEWCOGEN LLC

    • Director
    • 10% Owner
    		 6,760,843 2011-02-09 0

    AGTC PARTNERS, L.P.

    AGTC ADVISORS FUND LP

    APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP

    • 10% Owner
    		 2,491,460 2011-02-09 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    BG MEDICINE INC BGMD 2021-11-05 12:45:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 22:15:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 21:45:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 21:15:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 20:45:04 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 20:15:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 19:45:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 19:15:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 18:45:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 18:15:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 17:45:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 17:15:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 16:45:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 16:15:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 15:45:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 15:15:53 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 14:45:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 14:15:04 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 13:45:03 UTC -0.8354 0.9054 1000
    BG MEDICINE INC BGMD 2021-11-04 13:15:03 UTC -0.8354 0.9054 1000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments